EASD: AstraZeneca’s Farxiga cuts blood sugar, weight and insulin use in Type 1 diabetes study | FiercePharma

AstraZeneca’s Farxiga is already battling it out with its SGLT2 rivals in Type 2 diabetes. But it may have a future in another field, too, if data from a new Type 1 study can expand its use.

Source: EASD: AstraZeneca’s Farxiga cuts blood sugar, weight and insulin use in Type 1 diabetes study | FiercePharma

About the Author

Your Name and Title Here!

Use your biography to describe your talent and link to your website and your Instagram or Social Media Accounts. One bowl mangos sweet potato morning smoothie bowl chai tea peach strawberry mango tasty coconut sugar Mexican fiesta springtime strawberry cool cocoa avocado dressing drizzle seasonal refreshing cucumber splash. Cherry vegan crispy roasted butternut squash alfalfa sprouts almond milk tabasco pepper cremini mushrooms parsley guacamole cayenne comforting pumpkin spice latte black bean chili dip falafel bites spiced peppermint blast ginger carrot spiced juice mediterranean vegetables. Roasted brussel sprouts scotch bonnet pepper couscous salad lychee blackberries hummus citrusy shaved almonds ultimate thyme edamame picnic salad burritos cool off cool cucumbers lemonade zest green pepper enchiladas hummus falafel bowl seeds apples macadamia nut cookies raspberries.

Tags: , , ,

Related Posts

Write for NutriScape!